OraSure Technologies, Inc.
Index- P/E- EPS (ttm)-0.89 Insider Own2.80% Shs Outstand72.50M Perf Week-0.50%
Market Cap298.88M Forward P/E- EPS next Y-0.47 Insider Trans3.47% Shs Float69.77M Perf Month3.90%
Income-64.20M PEG- EPS next Q-0.04 Inst Own92.00% Short Float4.21% Perf Quarter39.86%
Sales265.40M P/S1.13 EPS this Y-44.50% Inst Trans-6.98% Short Ratio2.89 Perf Half Y-41.09%
Book/sh4.75 P/B0.84 EPS next Y24.20% ROA-14.40% Target Price5.33 Perf Year-62.93%
Cash/sh1.28 P/C3.12 EPS next 5Y20.00% ROE-17.40% 52W Range2.62 - 11.59 Perf YTD-53.97%
Dividend- P/FCF- EPS past 5Y-23.90% ROI-6.20% 52W High-65.49% Beta-0.01
Dividend %- Quick Ratio3.00 Sales past 5Y12.80% Gross Margin37.80% 52W Low52.67% ATR0.22
Employees785 Current Ratio4.10 Sales Q/Q39.20% Oper. Margin-22.50% RSI (14)53.39 Volatility5.28% 5.71%
OptionableYes Debt/Eq0.01 EPS Q/Q- Profit Margin-24.20% Rel Volume0.57 Prev Close4.02
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume1.02M Price4.00
Recom2.60 SMA201.54% SMA504.02% SMA200-29.49% Volume574,602 Change-0.50%
Sep-22-21Downgrade Raymond James Outperform → Mkt Perform
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Nov-02-17Downgrade Jefferies Buy → Hold
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Oct-01-22 10:30AM
Sep-28-22 10:28AM
Sep-20-22 04:05PM
Sep-14-22 07:05AM
06:29AM Loading…
Aug-31-22 06:29AM
Aug-14-22 08:28AM
Aug-09-22 07:25PM
Aug-02-22 07:05AM
Jul-28-22 07:05AM
Jul-14-22 08:42AM
Jun-14-22 08:31AM
Jun-08-22 04:05PM
07:05AM Loading…
May-25-22 07:05AM
May-23-22 04:05PM
May-17-22 07:05AM
May-10-22 06:55PM
May-04-22 06:45PM
May-03-22 04:05PM
Apr-24-22 10:21AM
Apr-07-22 07:05AM
Mar-31-22 07:05AM
Mar-22-22 04:05PM
Feb-23-22 04:05PM
Feb-16-22 04:05PM
Jan-31-22 07:54AM
07:05AM Loading…
Jan-25-22 07:05AM
Jan-24-22 10:04AM
Jan-19-22 05:38PM
Jan-13-22 04:05PM
Jan-06-22 11:09AM
Jan-05-22 04:24PM
Dec-14-21 07:05AM
Nov-30-21 07:05AM
Nov-19-21 07:05AM
Nov-11-21 09:34AM
Nov-09-21 07:05AM
Nov-08-21 07:05AM
Nov-04-21 12:31AM
Nov-03-21 07:15PM
Nov-02-21 12:25PM
Oct-27-21 03:03PM
Oct-04-21 03:39PM
Sep-23-21 10:00AM
Sep-20-21 06:00AM
Sep-10-21 11:14AM
Sep-02-21 07:00AM
Aug-03-21 11:01PM
Jul-28-21 03:04PM
Jul-27-21 04:01PM
Jul-12-21 07:28AM
Jun-17-21 04:05PM
Jun-14-21 06:00AM
Jun-07-21 10:38AM
May-28-21 07:00AM
May-26-21 09:21AM
May-18-21 07:00AM
May-17-21 07:00AM
May-12-21 06:00AM
May-10-21 06:00AM
May-06-21 01:01AM
May-05-21 05:25PM
Apr-30-21 04:01PM
Apr-28-21 12:34PM
Mar-30-21 07:00AM
Mar-10-21 10:29AM
Mar-01-21 08:31PM
Feb-26-21 10:09AM
Feb-24-21 04:01PM
Feb-18-21 06:00AM
Feb-10-21 12:31PM
Jan-29-21 06:00AM
Jan-28-21 08:02AM
Jan-27-21 08:55AM
Jan-26-21 07:57AM
Jan-25-21 06:00AM
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANCASTER RONNY BDirectorAug 26Buy4.0050,000200,000104,782Aug 29 05:08 PM
Aspinall Mara G.DirectorAug 25Buy4.196,00025,13877,218Aug 31 08:42 AM
Gagliano Nancy JDirectorAug 17Buy4.392,2009,65842,160Aug 22 06:54 PM
Celano MichaelDirectorAug 12Buy4.4912,00053,916111,823Aug 16 04:01 PM